1 min read
Add as a preferred source on GoogleImmuCell Preliminary Q3 Sales Reach $8.0 Million, Up 46.0%
Sales for the first nine months of 2026 totaled $25.6 million, up 27.8%.
ImmuCell Corporation posted preliminary sales of $8.0 million for the third quarter, a 46.0% increase. The company’s year-to-date sales through the first nine months of 2026 totaled $25.6 million, up 27.8%.
The third-quarter sales figure is preliminary.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.